Serotonin Syndrome Is Rare With Concomitant Use of Triptans and Serotonergic Antidepressants
March 11, 2018   

In this study, Orlova et al. set out to determine the validity of the 2006 FDA warning against increase risk of serotonin syndrome...
 Continue reading (Members only)
FDA Approves Lurasidone for Pediatric Bipolar Depression
March 8, 2018   

The US Food and Drug Administration (FDA) has approved lurasidone for the treatment of bipolar depression in pediatric patients (ages 10 to 17)...
 Continue reading (Members only)
UPDATE: New Guidelines Published for Diagnosis and Treatment of Depression in Adolescents in Primary Care
March 7, 2018   

Depression in children and adolescence is an enormous issue, especially given the potential risk for suicide in this young patient population. Unfortunately, in the primary care setting (which is where many patients are initially or solely seen by clinicians) as many as 2/3 of pediatric patients with depressive symptoms are not diagnosed...
 Continue reading
NIH Releases First Dataset from ABCD Study on Adolescent Brain Development
March 3, 2018   

The National Institutes of Health (NIH) released the first data from 4,500 participants in the Adolescent Brain Cognitive Development (ABCD) study....
 Continue reading (Members only)
Association Between Maternal Folic Acid Use and Risk of Austism Spectrum Disorder in Offspring
February 21, 2018   

The relationship between use of maternal folic acid and multivitamin supplements before and during pregnancy and risk of autism spectrum disorder (ASD) in offspring ...
 Continue reading (Members only)
Risk of Congenital Malformations With Stimulant Use During Pregnancy
February 16, 2018   

In a recent cohort study from the International Pregnancy Safety Consortium the relationship between intrauterine exposure to stimulants, such as methylphenidate and amphetamine and risk of...
 Continue reading
NEW Steps from FDA To Mitigate Opioid Overprescribing
February 13, 2018   

Given the widespread epidemic of prescribed opioid use disorder, including an alarming 40 opioid-related overdose deaths per day, the US Food and Drug Administration (FDA) released on January 30, 2018 a revised "blueprint" regarding the prescription of opioids...
 Continue reading (Members only)
Can Cannabis Use Reduce Opioid Use?
February 9, 2018   

Given the ongoing prescription opioid use disorder epidemic as well as the increasing legalization and availability of marijuana, the authors sought to determine whether marijuana use reduced the non-medical use of prescribed opioids...
 Continue reading
Review: Benefits vs. Risks of Aripiprazole During Pregnancy
February 7, 2018   

A systematic literature search and review evaluated the available data on the use of aripiprazole during pregnancy, peripartum and lactation...
 Continue reading (Members only)
Treatment With Propranolol Before Trauma Memory Reactivation May Reduce PTSD Symptoms
February 4, 2018   

Researcher found that trauma memory reactivation under the influence of propranolol showed a substantial reduction in posttraumatic stress disorder (PTSD) symptoms...
 Continue reading (Members only)
Top of Page